Dr. Cohen-Wolkowiez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-970-8231
Education & Training
- University of North CarolinaPhD, Pharmaceutical Sciences, 2007 - 2012
- Duke University HospitalFellowship, Pediatric Infectious Diseases, 2006 - 2009
- Nicklaus Children's HospitalResidency, Pediatrics, 2002 - 2006
- Central University of VenezuelaClass of 2001
Certifications & Licensure
- NC State Medical License 2006 - 2025
- MA State Medical License 2004 - 2009
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Metronidazole Pharmacokinetics (PK) in Premature Infants Start of enrollment: 2011 Jan 01
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Start of enrollment: 2011 Nov 01
- Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Population Pharmacokinetics of Meropenem Across the Adult Lifespan.Angelique E Boutzoukas, Stephen J Balevic, Marion Hemmersbach-Miller, Patricia L Winokur, Kenan Gu
Clinical Pharmacokinetics. 2025-02-01 - A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly.Daming Kong, Jason A Roberts, Jeffrey Lipman, Fabio Silvio Taccone, Michael Cohen-Wolkowiez
Clinical Pharmacokinetics. 2025-01-01 - Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial.Rachel L Randell, Laura E Schanberg, Claire Beard, Thomas Phillips, Christoph P Hornik
ACR Open Rheumatology. 2025-01-01
Press Mentions
- Early Stage Clinical Trial of Antimalarial Drug BeginsSeptember 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: